Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-011312
Filing Date
2015-02-23
Accepted
2015-02-23 12:27:53
Documents
1
Period of Report
2015-02-19

Document Format Files

Seq Description Document Type Size
1 form473091_20150223122643-.html 4  
1 form473091_20150223122643-.xml 4 3800
  Complete submission text file 0001144204-15-011312.txt   5383
Mailing Address 4045 SORRENTO VALLEY BOULEVARD SAN DIEGO CA 92121
Business Address 4045 SORRENTO VALLEY BOULEVARD SAN DIEGO CA 92121 908-864-4444
Sevion Therapeutics, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address WAKSAL CONSULTING LLC 7 NORTH WILLOW STREET, SUITE 6 MONTCLAIR NJ 07042
Business Address
Waksal Harlan (Reporting) CIK: 0001449008 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 15638795